| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185033 | Gynecologic Oncology | 2014 | 8 Pages |
Abstract
We established that amplifications in 14q32.33 were associated with reduced OS, PFS, PFI and platinum resistance in three independent cohorts, suggesting that AKT1 amplifications act as a potentially predictive marker for EOC treated with platinum-based chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Evelyn Despierre, Matthieu Moisse, Betül Yesilyurt, Jalid Sehouli, Ioana Braicu, Sven Mahner, Dan Cacsire Castillo-Tong, Robert Zeillinger, Sandrina Lambrechts, Karin Leunen, Frédéric Amant, Philippe Moerman, Diether Lambrechts, Ignace Vergote,